Assoc. Prof. Kullathorn Thephamongkhol, M.D.

Division : Radiation Oncology, Department of Radiology

Specialty groups : Head & Neck cancer, Breast cancer, Esophageal cancer, Cervical cancer, Pediatric cancer

Languages : Thai, English

Field of interests : Clinical epidemiology, Prediction research, Deep learning & Machine learning

Education
Year
2020
Ph.D candidate in clinical epidemiology, Faculty of Medicine, Thammasat University
2005
Research fellow (Meta-analyses of nasopharyngeal carcinoma) Institut Gustave Roussy, France
2003
Clinical and Research fellow Hamilton Regional Cancer Centre, McMaster University, Canada
1996
The Higher Graduate Diploma in Clinical Medical Sciences, Faculty of Medicine Siriraj hospital, Mahidol University
1995
Master of Science Program in Public Health Infectious Diseases and Epidemiology (International Program), Faculty of Public Health, Mahidol University
1991
Doctor of Medicine, Faculty of Medicine Siriraj hospital, Mahidol University
Certifications
Year
1998
Diploma, Thai Board of Radiation Oncology
1998
Diploma, Thai Board of General Radiology
1997
Medical radiation physics & radiobiology, The radiological society of Thailand
1992
Medical practice license, Thai medical council
Awards and honors
Year
2004
American Society of Clinical Oncology, Merit Award 2004 (Meta-analysis in NPC)
Professional memberships
Year
Present
Medical practice license, Thai medical council
Present
Radiation oncology, Thai Society of Therapeutic Radiology and Oncology
Recent publications
  1. Added value of metastatic cervical lymph node group V in nodal staging of nasopharyngeal cancer.
    Setakornnukul J, Thephamongkhol K, Chaysiri P. Head Neck. 2020 Oct;42(10):2801-2810. doi: 10.1002/hed.26325. Epub 2020 Jun 16. PMID: 32542997
  2. Rongthong W, Pleanarom S, Suntornpong N, Treechairusame T, Thephamongkhol K. Dosimetric study of craniospinal irradiation in children: intensity modulated radiation therapy vs. volumetric modulated arc therapy. J Thai Assn of Radiat Oncol 2020;26(2);R68-R76
  3. Veerasarn V, Janhom N, Chansilpa Y, Suntornpong N, Thephamongkhol K, Apiwarodom N, Petsuksiri J, Dankulchai P, Setakornnukul J, Teyateeti A, Rongthong W, Chaysiri P. The impact of active nutritional support for head and neck cancer patients receiving concurrent chemoradiotherapy. Siriraj Med J 2019;72(1):47-8.
  4. Rongthong W, Thepamongkol K, Suntornpong N. A retrospective study of the effects of craniospinal irradiation (CSI) on height in children with brain tumor. Siriraj Med J 2018;70(4);343-8
  5. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma. Setakornnukul J, Thephamongkhol K. BMC Cancer. 2018 Mar 27;18(1):329. doi: 10.1186/s12885-018-4210-3. PMID: 29587665
  6. Concurrent chemoradiotherapy for T3-4 and N0-1 nasopharyngeal cancer: Asian multicenter trial of the Forum for Nuclear Cooperation in Asia. Ohno T, Wakatsuki M, Thinh DH, Tung NT, Erawati D, Supriana N, Beena Devi CR, Kato S, Thephamongkhol K, Chansilpa Y, Calaguas MJ, Xiaoting X, Jianping C, Banu PA, Cho CK, Karasawa K, Nakano T, Tsujii H. J Radiat Res. 2016 Jan;57(1):44-9. doi: 10.1093/jrr/rrv046. Epub 2015 Aug 8. PMID: 26254458
  7. Concurrent chemoradiotherapy for T3-4 and N0-1 nasopharyngeal cancer: Asian multicenter trial of the Forum for Nuclear Cooperation in Asia. Ohno T, Wakatsuki M, Thinh DH, Tung NT, Erawati D, Supriana N, Beena Devi CR, Kato S, Thephamongkhol K, Chansilpa Y, Calaguas MJ, Xiaoting X, Jianping C, Banu PA, Cho CK, Karasawa K, Nakano T, Tsujii H. J Radiat Res. 2016 Jan;57(1):44-9. doi: 10.1093/jrr/rrv046. Epub 2015 Aug 8. PMID: 26254458
  8. Improving breast cancer detection using ultrasonography in asymptomatic women with non-fatty breast density.
    Korpraphong P, Limsuwarn P, Tangcharoensathien W, Ansusingha T, Thephamongkhol K, Chuthapisith S. Acta Radiol. 2014 Oct;55(8):903-8. doi: 10.1177/0284185113507711. Epub 2013 Oct 8. PMID: 24103915
  9. Long term outcomes of patients with endometrial carcinoma treated with radiation – Siriraj Hospital experience.
    Setakornnukul J, Petsuksiri J, Wanglikitkoon S, Warnnissorn M, Thephamongkhol K, Chansilp Y, Veerasarn V. Asian Pac J Cancer Prev. 2014;15(5):2279-85. doi: 10.7314/apjcp.2014.15.5.2279. PMID: 24716970 
  10. Posterior cervical lymph node metastasis as the valuable prognostic factor for stage IVA/IVB nasopharyngeal carcinoma treated with induction chemotherapy followed by concurrent chemo-radiotherapy. Thephamongkhol K, Setakornnukul J, Rojwatkarnjana S, Chansilpa Y. Int J Biol Markers. 2014 Dec 9;29(4):e387-94. doi: 10.5301/jbm.5000106. PMID: 25198554
  11. Randomized trials of amifostine and radiotherapy: effect on survival?
    Bourhis J, Thephamongkhol K, Pignon JP. Semin Oncol. 2004 Dec;31(6 Suppl 18):62-6. doi: 10.1053/j.seminoncol.2004.12.015. PMID: 15726526 Review.
  12. Comparison of 18F-FDG Pet/CT and CT: diagnosis performance in lymphoma patient after treatment.
    Chiewvit S, Thephamongkhol K, Ubolnuch K, Pooliam J, Phongsawat N, Chiewvit P. J Med Assoc Thai. 2014 Jan;97(1):85-94. PMID: 24701734
  13. Long-term follow-up results of a multi-institutional phase 2 study of concurrent chemoradiation therapy for locally advanced cervical cancer in east and southeast Asia. Kato S, Ohno T, Thephamongkhol K, Chansilpa Y, Cao J, Xu X, Devi CR, Swee TT, Calaguas MJ, de Los Reyes RH, Cho CK, Dung TA, Supriana N, Erawati D, Mizuno H, Nakano T, Tsujii H. Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):100-5. doi: 10.1016/j.ijrobp.2013.04.053. PMID: 23920390
  14. Radiotherapy concurrently with weekly cisplatin, followed by adjuvant chemotherapy, for N2-3 nasopharyngeal cancer: a multicenter trial of the Forum for Nuclear Cooperation in Asia. Ohno T, Thinh DH, Kato S, Devi CR, Tung NT, Thephamongkhol K, Calaguas MJ, Zhou J, Chansilpa Y, Supriana N, Erawati D, Banu PA, Koo CC, Kobayashi K, Nakano T, Tsujii H. J Radiat Res. 2013 May;54(3):467-73. doi: 10.1093/jrr/rrs115. Epub 2012 Nov 28. PMID: 23192700
  15. Single-bundle versus double-bundle anterior cruciate ligament reconstruction: a meta-analysis.
    Lamsam C, Kaewpornsawan K, Luangsa-Ard J, Thephamongkhol K, Vanadurongwan B, Soparat K. J Med Assoc Thai. 2012 Sep;95 Suppl 9:S114-21. PMID: 23326993
  16. Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients.
    Petsuksiri J, Sermsree A, Thephamongkhol K, Keskool P, Thongyai K, Chansilpa Y, Pattaranutaporn P. Radiat Oncol. 2011 Feb 20;6:19. doi: 10.1186/1748-717X-6-19. PMID: 21333025
  17. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia. Kato S, Ohno T, Thephamongkhol K, Chansilpa Y, Yuxing Y, Devi CR, Bustam AZ, Calaguas MJ, de los Reyes RH, Cho CK, Dung TA, Supriana N, Mizuno H, Nakano T, Tsujii H. Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):751-7. doi: 10.1016/j.ijrobp.2009.06.011. Epub 2009 Oct 14. PMID: 19836154
  18. Prognostic factors and treatment outcomes of retinoblastoma in pediatric patients: a single-institution study.
    Atchaneeyasakul LO, Wongsiwaroj C, Uiprasertkul M, Sanpakit K, Thephamongkhol K, Trinavarat A. Jpn J Ophthalmol. 2009 Jan;53(1):35-39. doi: 10.1007/s10384-008-0614-y. Epub 2009 Jan 30. PMID: 19184307
  19. Does magnetic resonance imaging give value-added than bone scintigraphy in the detection of vertebral metastasis?
    Chiewvit P, Danchaivijitr N, Sirivitmaitrie K, Chiewvit S, Thephamongkhol K. J Med Assoc Thai. 2009 Jun;92(6):818-29. PMID: 19530588
  20. Treatment options in bulky stage IB cervical carcinoma.
    Petsuksiri J, Chansilpa Y, Therasakvichya S, Suntornpong N, Thephamongkhol K, Dankulchai P, Mahasitthiwat P, Ieumwananonthachai N, Veerasarn V, Sangruchi S, Pattaranutaporn P. Int J Gynecol Cancer. 2008 Nov-Dec;18(6):1153-62. doi: 10.1111/j.1525-1438.2008.01195.x. Epub 2008 Feb 19. PMID: 18298563
  21. A regional cooperative clinical study of radiotherapy for cervical cancer in east and south-east Asian countries.
    Nakano T, Kato S, Cao J, Zhou J, Susworo R, Supriana N, Sato S, Ohno T, Suto H, Nakamura Y, Cho CK, Ismail FB, Calaguas MJ, de Los Reyes RH, Chansilpa Y, Thephamongkhol K, Duc NB, Dung TA, Tsujii H. Radiother Oncol. 2007 Sep;84(3):314-9. doi: 10.1016/j.radonc.2007.05.012. Epub 2007 May 29. PMID: 17532495
  22. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT, Kwong DL, Al-Sarraf M, Chi KH, Hareyama M, Leung SF, Thephamongkhol K, Pignon JP; MAC-NPC Collaborative Group. Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):47-56. doi: 10.1016/j.ijrobp.2005.06.037. PMID: 16377415
  23. Randomized trials of amifostine and radiotherapy: effect on survival?
    Bourhis J, Thephamongkhol K, Pignon JP. Semin Oncol. 2004 Dec;31(6 Suppl 18):62-6. doi: 10.1053/j.seminoncol.2004.12.015. PMID: 15726526
  24. Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. Sawka AM, Thephamongkhol K, Brouwers M, Thabane L, Browman G, Gerstein HC. J Clin Endocrinol Metab. 2004 Aug;89(8):3668-76. doi: 10.1210/jc.2003-031167. PMID: 15292285
  25. Adjuvant radiotherapy in women with stage I endometrial cancer: a systematic review.
    Lukka H, Chambers A, Fyles A, Thephamongkhol K, Fung-Kee-Fung M, Elit L, Kwon J. Gynecol Oncol. 2006 Aug;102(2):361-8. doi: 10.1016/j.ygyno.2006.03.008. Epub 2006 May 2. PMID: 16631237
  26. Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma.
    Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT, Kwong DL, Al-Sarraf M, Chi KH, Hareyama M, Leung SF, Thephamongkhol K, Pignon JP; MAC-NPC Collaborative Group. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004329. doi: 10.1002/14651858.CD004329.pub2. PMID: 17054200
  27. Concurrent radiation therapy and irinotecan in stage IIIB cervical cancer.
    Suntornpong N, Pattaranutaporn P, Chanslip Y, Thephamongkhol K. J Med Assoc Thai. 2003 May;86(5):430-5. PMID: 12859099
  28. Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma.
    Pattaranutaporn P, Thirapakawong C, Chansilpa Y, Therasakvichya S, Ieumwananontachai N, Thephamongkhol K. Gynecol Oncol. 2001 Jun;81(3):404-7. doi: 10.1006/gyno.2001.6197. PMID: 11371129 Clinical Trial.